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Abstract
Persistent infection with the hepatitis C virus (HCV) is a major risk factor for the development of liver cirrhosis and
hepatocellular carcinoma. With an estimated about 3% of the world population infected with this virus, the lack of a
prophylactic vaccine and a selective therapy, chronic hepatitis C currently is a main indication for liver transplantation. The
establishment of cell-based replication and virus production systems has led to first insights into the functions of HCV
proteins. However, the role of nonstructural protein 5A (NS5A) in the viral replication cycle is so far not known. NS5A is a
membrane-associated RNA-binding protein assumed to be involved in HCV RNA replication. Its numerous interactions with
the host cell suggest that NS5A is also an important determinant for pathogenesis and persistence. In this study we show
that NS5A is a key factor for the assembly of infectious HCV particles. We specifically identify the C-terminal domain III as the
primary determinant in NS5A for particle formation. We show that both core and NS5A colocalize on the surface of lipid
droplets, a proposed site for HCV particle assembly. Deletions in domain III of NS5A disrupting this colocalization abrogate
infectious particle formation and lead to an enhanced accumulation of core protein on the surface of lipid droplets. Finally,
we show that mutations in NS5A causing an assembly defect can be rescued by trans-complementation. These data provide
novel insights into the production of infectious HCV and identify NS5A as a major determinant for HCV assembly. Since
domain III of NS5A is one of the most variable regions in the HCV genome, the results suggest that viral isolates may differ in
their level of virion production and thus in their level of fitness and pathogenesis.
Citation: Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, et al. (2008) Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious
Particle Assembly. PLoS Pathog 4(3): e1000035. doi:10.1371/journal.ppat.1000035
Editor: Darius Moradpour, University of Lausanne, Switzerland
Received December 27, 2007; Accepted March 3, 2008; Published March 28, 2008
Copyright:  2008 Appel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Deutsche Forschungsgemeinschaft (BA1505/2-1), the Sonderforschungsbereich 638 (Teilprojekt A5 to
R.B.), and the CellNetworks Cluster of Excellence at the University of Heidelberg.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Ralf_Bartenschlager@med.uni-heidelberg.de
¤a Current address: EMBL Heidelberg, Cell Biology/Cell Biophysics Programme, Heidelberg, Germany
¤b Current address: 3V Biosciences, Institute of Biochemistry, ETH Hoenggerberg HPME 17, Zurich, Switzerland
¤c Current address: Centre for Virology, Department of Infection and Immunity, University College London, London, United Kingdom
¤d Current address: Nikon Imaging Center at the University of Heidelberg, Bioquant, Heidelberg, Germany
. These authors contributed equally to this work.
Introduction
The hepatitis C virus (HCV) is a major causative agent of acute
and chronic liver diseases worldwide [1]. A hallmark of HCV
infection is the high persistence, which is unusual for a virus of this
group and which has been explained by numerous active and
passive immune evasion strategies [2,3]. Although primary
infection is often asymptomatic or associated with mild and non-
specific symptoms, persistently infected persons have a high risk to
develop chronic liver diseases in the course of one or several
decades, the most serious outcomes being liver cirrhosis and
hepatocellular carcinoma. It is this property of HCV infection and
its high prevalence that explain the high medical relevance of this
pathogen. Moreover, therapeutic options are limited and there is
no prophylactic vaccine in sight [4,5].
The genome of HCV is a single strand RNA of positive polarity
[6]. This RNA has a length of about 9,600 nucleotides and a very
simple organization with only one long open reading frame. It is
flanked by non-translated regions at the 59 and 39 end of the
genome that are required for RNA translation and replication.
The open reading frame encodes for an about 3,000 amino acids
long polyprotein that is cleaved co- and post-translationally by
cellular and viral proteases into 10 different products. The
structural proteins core, envelope protein 1 (E1) and E2 that
build up the virus particle reside in the N-terminal region of the
polyprotein and they are processed by host cell signalases and by
signal peptide peptidase. C-terminal of E2 is the p7 protein that is
required for virus assembly, release [7,8] and for infectivity in vivo
[9]. The remainder of the polyprotein is processed into the
nonstructural proteins 2 (NS2), NS3, NS4A, NS4B, NS5A and
NS5B. NS2 is a cysteine protease that cleaves at the NS2-3 site and
that in addition is required for virus production [7]. NS3 is a
bifunctional molecule that carries a serine-type protease activity in
the N-terminal domain and a NTPase/helicase activity in the
remainder. NS4A is a co-factor of the NS3 protease whereas
NS4B is required for the induction of membrane alterations that
probably serve as the scaffold for the formation of the membrane-
associated replication complex. NS5A is an RNA binding protein
assumed to be involved in some step of viral RNA replication and
NS5B is the RNA-dependent RNA polymerase.
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production of infectious HCV particles, we and others have
recently gained first insights into the mechanisms underlying HCV
particle assembly [10–12]. A key player of this process is the core
protein. It is composed of an RNA binding domain, a domain for
lipid droplet (LD) targeting (domain 2) and a very hydrophobic C-
terminal domain (domain 3) that serves as the signal sequence of
the C-terminal E1 protein [13,14]. Building on earlier observa-
tions that core protein accumulates on the surface of LDs [15,16]
it was proposed that LDs are involved in the formation of
infectious particles. A model was put forward by which core
protein recruits the HCV replication complex (RC) to the surface
of LDs where virus particle formation may be triggered [10].
Accumulation of core protein on the surface of LDs requires
proteolytic removal of domain 3 by signal peptide peptidase [17].
This domain usually anchors the core protein to the ER
membrane bilayer and thus precludes mobilization onto the
surface of LDs that are surrounded by a monolayer membrane.
However, upon removal of domain 3, core becomes mobile and
this mobility critically determines efficient virus assembly [11,12].
Since the core protein accumulates on the surface of LDs
whereas the viral RC probably resides on ER or ER-derived
membranes, nucleocapsid formation requires the translocation of
the viral genome from the RC to core proteins. Cell culture
adaptive mutations that enhance virus titres by up to several orders
of magnitude without affecting RNA replication have been
mapped to the nonstructural proteins constituting the RC. This
led to the suggestion that the RC or non-structural proteins may
play a role in this putative transfer of the viral genome to the core
[18–21]. Indeed, one hot-spot of adaptation was found within
NS5A arguing that this nonstructural protein may be an element
involved in HCV assembly [21].
NS5A is an RNA binding phospho protein composed of 3
domains that are separated by trypsin-sensitive low complexity
sequences (LCS I and LCS II) and an N-terminal amphipathic
alpha-helix that stably anchors the protein to intracellular
membranes [22–24]. According to the X-ray crystal structure of
domain I, it forms a dimer with a claw-like shape that can
accommodate a single strand RNA molecule [25]. The role of
domain II and domain III of NS5A in the HCV replication cycle is
unknow. However replication enhancing mutations were mapped
to a region spanning the C-terminal part of domain I and LCS I
arguing that these sequences are important for efficient RNA
replication [26,27]. In contrast, domain III can be deleted or
replaced by green fluorescent protein with no dramatic effect on
RNA replication [28,29].
Taking advantage of a highly efficient HCV particle production
system, in this study we identified a novel function of NS5A and
demonstrate its crucial role in infectious virion assembly. Our data
specifically identify domain III in NS5A as a key element in
particle formation and provide insight how mutations in this
domain lead to accumulation of core protein on LDs and thus may
contribute to pathogenesis.
Results
Impact of NS5A deletions on HCV RNA replication
To identify the role of domains II and III of NS5A in the viral
replication cycle we utilized the chimeric Jc1 genome and inserted
a series of in frame deletions into the NS5A coding region
(Figure 1). Since NS5A is a component of the HCV replication
machinery, we first assessed the impact of these mutations on
RNA replication in the context of a well established luciferase
reporter virus genome (Jc1-Luc; Figure 1A). In vitro transcripts of
these Jc1-Luc constructs were transfected into highly permissive
Huh7-Lunet cells in parallel with the Jc1-Luc wild type genome
and a deletion mutant that lacked part of the envelope
glycoproteins (Jc1-Luc/DE1E2). RNA replication was monitored
by determination of luciferase activity at 4, 24, 48 and 72 h post
transfection. The 4 h value was used for normalization and
allowed correction for different transfection efficiencies [27]. As
shown in Figure 2A, a deletion spanning almost the complete
domain II and retaining only the C-terminal 35 amino acid
residues did not affect RNA replication (mutant D2222-2280).
However, complete removal of domain II abrogated RNA
replication (not shown) arguing that the extreme C-terminal
sequence of domain II is essential for RNA replication. Complete
or partial deletion of domain III of NS5A had no significant
impact on RNA replication. Although mutants D2328-2435,
D2354-2435 and D2354-2404 showed a clearly reduced replica-
tion level at 24 h post transfection, this was overcome 48 h or at
latest 72 h after transfection arguing that these deletions had a
rather moderate effect on RNA replication (Figure 2A). Analogous
results were obtained by using reporter-free Jc1 constructs for
transfection and RNA determination by Northern-blot (not
shown). Based on these results we concluded that most of domain
II (D2222-2280) and the complete domain III (D2328-2435) are
not essential for RNA replication even though some of the
deletions in domain III clearly delayed RNA replication kinetics.
Block of HCV particle assembly by deletion of NS5A
domain III
In the light of these surprising results we argued that domain II
and domain III may have some other function, most notably in
virus assembly and release. Given the impaired capacity of the
luciferase reporter genomes to support infectious virus production,
in all subsequent experiments only reporter-free constructs were
used (Figure 1A). To determine the impact of the NS5A deletion
mutants on virus production we quantified core protein amounts
in cells transfected with the various mutants and in the
corresponding culture supernatants at different time points after
transfection by using a core-specific ELISA (Figure 2B, left and
right panel, respectively). To account for different efficiencies of
core protein accumulation within cells and core protein release, we
Author Summary
The hepatitis C virus (HCV) is a major cause of acute and
chronic liver diseases worldwide. In spite of high medical
need there is no selective antiviral therapy available and a
prophylactic vaccine is not in sight. Their development
requires cellular replication systems that have become
available just recently. One of the most fascinating insights
gained with these systems is the finding that infectious
HCV particles assemble in close association with an
intracellular lipid storage compartment termed lipid
droplets. In this study we show that nonstructural protein
5A (NS5A), a component of the viral RNA replication
machinery is a key factor for the formation of infectious
HCV particles. We identify a distinct domain in NS5A as the
primary ‘‘assembly determinant’’ and show that NS5A and
the core protein, which is a major constituent of the virus
particle, accumulate on the surface of lipid droplets.
Deletions in NS5A disrupting the colocalization of core
and NS5A on lipid droplets abrogate infectious HCV
production. These studies unravel a unique pathway of
infectious virus formation and identify NS5A as a factor
modulating HCV replication and assembly and thus viral
fitness.
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amounts detected in the culture supernatant to total core protein
amounts (intra- and extracellular core) (Figure 2C). Cells
transfected with Jc1 released about 50–60% of total core protein
into the supernatant. In contrast, relative core protein amounts
released from cells that had been transfected with domain II
deletion mutant D2222-2280 were somewhat reduced and ranged
between 40% of total core at early time points after transfection
and only 20% 72 h post transfection (Figure 2C). In case of the
domain III deletion (D2328-2435) extracellular core was almost
undetectable arguing for an important role of this NS5A domain
for virus release. To map the region within this domain required
for infectious particle production three smaller deletions were
generated. Retention of the N-terminal 26 amino acid residues of
domain III did not restore core release (D2354-2435). Inclusion of
the 77 N-terminal residues (D2405-2435) restored core release to
only about 0.5–1% of the wild type (Figure 2C). However, when
we retained the N-terminal 26 and the C-terminal 38 amino acid
residues, core release comparable to wild type level was observed
(D2354-2404). These results suggest that the C-terminal region
residing between amino acid residues 2404 and 2435 of domain III
are crucial for virus production.
In order to study the impact of the deletions in domains II and
III of NS5A on assembly and release of infectious HCV particles,
infectivity titers in the culture supernatant at 24, 48 and 72 h after
transfection with the various mutants, the Jc1 wild type or the
envelope glycoprotein deletion mutant (Jc1/DE1E2) were deter-
mined by using TCID50 assays. As shown in Figure 2D, infectivity
titers of the wild type were in the range of 10
6 TCID50/ml at early
time points after transfection whereas no infectivity was detected at
all time points in case of Jc1/DE1E2. Infectivity titers obtained
with the domain II deletion mutant that still supports core release
(D2222-2280) were clearly reduced 48 and 72 h p.t. as compared
to wild type and this reduction correlated with the reduction of
core release (Figure 2C). In agreement with the strongest
impairment of core release, almost no infectivity could be detected
Figure 1. Schematic representation of constructs used in this study. (A) Structure of chimeric HCV genomes consisting of the coding region
of core up to the first transmembrane segment of NS2 derived from the genotype 2a isolate J6CF and the remainder of the JFH-1 isolate. Jc1/DE1E2
carries an in-frame deletion of 350 codons within the E1-E2 coding region (indicated by dotted boxes). Jc1/DE1E2+D2328-2435 carries an additional
deletion of domain III of the NS5A coding sequence. The structure of the genomic luciferase reporter virus genome is drawn below. It is a bicistronic
RNA with the first cistron encoding the firefly luciferase gene (Luc) expressed via the HCV IRES whereas the polyprotein is expressed via the IRES of
the encephalomyocarditis virus (E–I). This construct design is analogous to the one of the subgenomic helper RNA (sgLuc/wt; schematic in the
bottom). However, it lacks the coding region from core to NS2 and was used for trans-complementation assays. (B) Domain structure of NS5A (upper
panel) and deletion mutations in domains II and III (lower panels). For details see text. The structures of the deletion mutants lacking all or parts of
domain II or domain III are shown below and their designation is given in the right. Numbers indicate the last and the first amino acid position
flanking the deletion or the N- and the C-terminus of JFH-1 NS5A.
doi:10.1371/journal.ppat.1000035.g001
Essential Role of NS5A for HCV Assembly
PLoS Pathogens | www.plospathogens.org 3 March 2008 | Volume 4 | Issue 3 | e1000035Figure 2. Transient replication of NS5A deletion mutants and release of virus from cells transfected with these genomes. (A) Huh7-
Lunet cells were transfected with luciferase reporter virus constructs specified in the bottom. Cells were lysed at given time points after transfection
and luciferase activity was determined. A representative experiment of three independent repetitions, each value measured in duplicate is shown.
Note that the luciferase reporter genomes have a delayed replication kinetic compared to reporter-free genomes [56] and that Huh7-Lunet cells
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domain III mutants carrying the largest deletions (D2328-2435
and D2354-2435). Deletion of amino acid residues 2354–2404 or
2405–2435 resulted in about 10-fold or 100-fold lower titers as
compared to the Jc1 wild type, respectively (Figure 2D). These
results were fully confirmed when we analyzed the analogous
luciferase reporter virus genomes (Figure 2A) by determining
luciferase transduction efficiency upon infection of naive Huh7.5
cells (not shown).
During these analyses we noted that cells transfected with Jc1/
DE1E2, which lacks part of the envelope glycoprotein ectodo-
mains, still released well detectable amounts of core protein, but
no infectivity. We therefore assumed that this core release is either
non-specific, for instance due to cytotoxicity, or that part of the
core protein can be released independent from the envelope
glycoproteins. To address these possibilities, we constructed a
double mutant which contained both the deletion in the E1E2-
coding region and the largest deletion in domain III of NS5A (Jc1/
DE1E2/D2328-2435). Interestingly, cells transfected with this
mutant released much lower amounts of core protein as compared
to Jc1/DE1E2 (Figure 2B, C), arguing that a fraction of core
protein can be released independent from functional envelope
glycoproteins, but still in an NS5A-dependent manner.
Impact of NS5A domain III deletions on HCV particle
release
The results described above clearly show that domain III plays a
primary role in the production of infectious HCV particles, but do
not address the question whether assembly or release of these
particles is affected. In case of a block of particle release, we would
expect an accumulation of cell-associated (intracellular) infectious
particles and thus a change of the ratio of extra- over intracellular
infectivity. To address this possibility intracellular infectivity titers
were compared to the corresponding supernatants. In case of the
Jc1 wild type, about 90% of total infectivity was released into the
supernatant and only 10% was detectable in transfected cells
(Figure 3). A similar ratio was found with the domain II deletion
mutant (D2222-2280) and the deletion mutation retaining the 26
N-terminal and 38 C-terminal amino acid residues of domain III
(D2354-2404). In case of the two largest domain III deletion
mutants (D2328-2435 and D2354-2435) intra- and extracellular
infectivity titers were reduced by up to 4 orders of magnitude
arguing that primarily, if not exclusively, infectious particle
assembly was affected. No significant change of extra- over
intracellular infectivity was found with the smallest deletion
mutant lacking 31 amino acid residues close to the C-terminus
of domain III (D2405-2435), but titer reduction was much less
pronounced as compared to the two largest deletion mutants.
These findings were confirmed for cells and supernatants
harvested 72 h post transfection (data not shown). We therefore
conclude that the deletion mutations residing in domain III
affected assembly of infectious virus particles and had little or no
effect on virus release.
Influence of deletions in domain II and III on the
phosphorylation status of NS5A
Having confirmed an important role of NS5A for virus
assembly, we assumed that NS5A might regulate the formation
of HCV particles in a phosphorylation dependent manner and
that the deletions we had inserted impact the phosphorylation
status of this protein. To test this hypothesis we analyzed the
phosphorylation status of the different truncated NS5A proteins by
one-dimensional SDS-PAGE after phosphatase treatment. Huh7-
Lunet cells were transfected with the different HCV genomes and
harvested 72 h after transfection for Western blot analysis
(Figure 4). In case of Jc1 the two phosphorylated variants of
NS5A, the p56 basal phosphorylated form and the p58 hyperpho-
sphorylated form, were readily detectable. After dephosphoryla-
tion of the proteins with l-phosphatase, the p58 variant
disappeared and the p56 variant migrated slightly faster than the
non-treated protein, showing that both forms were phosphatase
sensitive. For all domain III mutants, a basally and a hyperpho-
sphorylated variant of NS5A were detected. The only mutant that
showed a clear reduction in the amount of hyperphosphorylated
NS5A carried the deletion in domain II (D2222-2280). Since this
deletion did not significantly affect RNA replication and particle
Figure 3. Efficiency of virus assembly and release of Jc1
carrying deletions in NS5A. Huh7-Lunet cells were transfected with
the genomes specified in the bottom and 48 h post transfection total
infectious particle production was determined. Supernatants and cells
were treated by freeze-thaw cycles and viral infectivity was determined
by a limiting dilution assay. Mean values of four independent
experiments are shown and the standard deviations of the means are
presented. The grey bar represents the detection limit of the assay.
doi:10.1371/journal.ppat.1000035.g003
support HCV spread only poorly [57]. Therefore, luciferase levels in transfected cultures are not affected by virus release and spread and thus reflect
almost exclusively RNA replication. (B) Kinetic of intracellular accumulation of core protein (left panel) and release of core protein (right panel) from
Huh7-Lunet cells transfected with reporter-free Jc1 constructs. Core amounts were determined by using core-specific ELISA. Intracellular core
amounts were normalized to the 4h value that reflects transfection efficiency. A representative experiment of at least three independent repetitions is
given in each panel. (C) Efficiency of core protein release from cells transfected with reporter-free Jc1 or given mutants. The percentage of released
core protein in relation to total core protein (the sum of intra and extracellular core protein) was calculated for each time point. A representative
experiment of three independent repetitions is shown. (D) Release of infectivity from cells transfected with reporter-free Jc1 or mutants specifiedi n
the top by using a limiting dilution assay. Cell free culture fluids were harvested at different time points after transfection and titrated to determine
viral infectivity of the indicated genomes.The grey bar represents the detection limit of the assay.
doi:10.1371/journal.ppat.1000035.g002
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hyperphosphorylated NS5A (not detectable in this assay) are
sufficient for RNA replication and particle assembly or that
hyperphosphorylated NS5A is dispensable for these processes.
Deletion of domain III of NS5A results in a loss of
colocalization of NS5A and core protein on lipid droplets
We have recently shown that the core protein appears to recruit
the HCV replicase and the RNA genome to LDs, which may be
the site for the assembly of infectious HCV particles [10]. Since
deletions in domain III very much impair particle assembly, we
assumed that these mutations may affect either the localization of
NS5A on LDs per se or the core-dependent recruitment of NS5A to
LDs. To address these possibilities we first studied the subcellular
localization of the HCV proteins in cells transfected with the
NS5A mutants or the Jc1 wild type or the E1-E2 deletion mutant.
Seventy two hours after transfection cells were fixed and stained
for NS5A, core protein and LDs. In case of Jc1 wild type, core
protein accumulated on LDs (Figure 5, panel II). In addition, low
amounts of NS5A were also found on LDs and this NS5A species
colocalized with the core protein (panel IV and V, respectively). In
agreement with our earlier report [11], core accumulation on LDs
was very much pronounced when assembly was blocked at a
rather late stage, which we achieved here by partial deletion of the
ectodomains of E1 and E2 (Jc1/DE1E2) (Figure 5, panel XII).
Concommitant with core protein accumulation, we also found an
accumulation of NS5A on LDs and a perfect colocalization with
the core protein (panel XIV and XV, respectively). Interestingly, in
case of the mutant with the strongest impact on infectious particle
assembly (Jc1/D2328-2435), both NS5A and core protein still
accumulated on the surface of LDs (Figure 5, panel VII, IX), but
their colocalization on the same LDs was no longer detectable
(panel X). The same phenotype was found with the double deletion
mutant Jc1/DE1E2+D2328-2435 (Figure 5, panel XVI to XX).
A more quantitative analysis of core and NS5A colocalization
on LDs fully confirmed this observation (Figure 6A, upper panel).
Including the other NS5A mutants in the analysis, a clear
correlation between core – NS5A colocalization on LDs and the
efficiency of core release was detected. Most notably those
deletions in domain III of NS5A that severely reduced the
assembly of infectious particles also reduced core – NS5A
colocalization on LDs (Figure 6A, upper panel and Figure 6B).
Interestingly, when we determined the colocalization of all these
NS5A proteins with NS4B, which is most likely an integral
component of the HCV replication complex, none of the
mutations affected the colocalization with NS4B (Figure 6A,
upper panel). This observation is consistent with the result that the
NS5A mutants support HCV RNA replication, in most cases
comparable to wild type levels. The data thus imply that NS5A
may exist in two different complexes. One complex containing the
core protein and presumably responsible for particle assembly, and
one complex containing NS4B and probably representing the
(membranous) replication complex. Alternatively, NS5A may exist
Figure 5. Deletion of domain III of NS5A abolishes NS5A
colocalization with core on LDs. Huh7-Lunet cells were transfected
with Jc1 (panel I to V), Jc1/D2328-2435 (panel VI to X), Jc1/DE1E2 (panel
XI to XV), and Jc1/DE1E2+D2328-2435 (panel XVI to XX) and fixed 72 h
post transfection. Fixed cells were analyzed for the subcellular
localization patterns of core (red) and NS5A (blue) by immunofluores-
cence whereas LDs were stained with BODIPY493/503 (green). Images
were generated with a spinning disk confocal and they represent single
optical planes. The locations of the 4 cropped sections shown for each
of the constructs in the right are boxed in each overview panel. Scale
bars represent 5 mm and 1 mm in single cell and cropped sections,
respectivetly.
doi:10.1371/journal.ppat.1000035.g005
Figure 4. Analysis of the phosphorylation status of NS5A
expressed from Jc1, Jc1/DE1E2 and Jc1-derived NS5A mutants.
Huh7-Lunet cells were transfected with the indicated genomes and
lysed in RIPA buffer 72 h post transfection. Cell lysates were treated
with aceton/methanol and one-half of the precipitated protein was
incubated with l-phosphatase whereas the other half was mock treated
in phosphatase buffer. Both samples were separated by 8% SDS-PAGE
and NS5A was detected by Western blot. The positions of p56 and p58
are indicated in the left.
doi:10.1371/journal.ppat.1000035.g004
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no longer recruited to the core protein on the surface of LDs in
case of the mutant lacking domain III.
Another interesting observation emerged when we quantified
the core protein accumulating on the surface of LDs in cells
transfected with the various HCV genomes. As summarized in the
lower panel of Figure 6A, core protein accumulation was highest
for those NS5A mutants that do not support production of
infectious virus particles (D2328-2435 and D2354-2435). In
contrast, overall only low amounts of core co-localized on the
surface of LDs in case of the Jc1 wild type, even though in a few
cells colocalization was extensive (one example is shown in
Figure 5). Likewise, in cells transfected with the NS5A mutants
D2222-2280 and D2354-2404 that both support efficient virus
production (see also Figure 2D), only about 20% of LDs
colocalized with core. An intermediate phenotype was found in
case of the D2405-2435 NS5A mutant that supported about 100-
fold lower virus titers as compared to wild type. This result
correlates with the model that core protein residing on the surface
of LDs is involved in virion assembly and that inefficient assembly
results in an accumulation of core on LDs. In agreement with that
assumption, core protein accumulation on the surface of LDs was
also observed with the envelope deletion mutant (Jc1/DE1E2).
However, in this case we observed a colocalization of core and
NS5A, unlike the assembly-incompetent NS5A mutants.
Although the data described thus far suggested that NS5A
mutants lacking domain III no longer colocalized with core on the
surface of LDs, the level of resolution achieved with these assays
did not allow us to draw a firm conclusion about the localization of
NS5A and core protein relative to each other. We therefore
analyzed cells transfected with the NS5A domain III deletion
mutant Jc1/D2328-2435 in parallel to cells transfected with Jc1
wild type or the envelope deletion mutant (Jc1/DE1E2) by using
deconvolution of images generated by spinning disk confocal
microscopy. As shown in Figure 7A, in Jc1 transfected cells the
core protein localized directly to the surface of the droplets, often
in association with NS5A (structure 1 in Figure 7A, upper panel).
In some other cases NS5A was directly associated with the surface
of LDs whereas the core protein accumulated at a distinct spot on
the droplet surface which may correspond to the loading site of
core onto LDs [12] (structure 2 in Figure 7A, upper panel). In case
of the envelope deletion mutant, core and NS5A still colocalized
(arrows in Figure 7A) and core staining was much more intense
reflecting an accumulation of core protein on the surface of LDs
due to an assembly defect. A comparably high core accumulation
on LD surfaces was found with the NS5A domain III deletion
Figure 6. Mutations in domain III of NS5A impairing virus assembly also impair colocalization of NS5A with core protein on LDs. (A)
The quantitation of colocalization between NS5A and core protein, or NS5A and NS4B in a population of 50 cells per construct is shown in the upper
panel. For the measurement of the degree of colocalization, the correlation coefficients between the signal obtained for the respective proteins were
calculated by using the plugin ‘Intensity correlation analysis’ of Image J. The lower panel summarizes the association of core protein and LDs in cells
transfected with the constructs specified between both panels. For calculation of the percentage of core protein associated with LDs about 2,000 to
2,500 LDs were counted for each construct and colocalization with core protein was analyzed by using the plugin ‘RG2B colocalization’ of Image J.
Error bars in both panels represent the standard errors of the means of 10 to 15 cells per construct. (B) Representative confocal immunofluorescence
images of cells transfected with the constructs as specified in panel A.
doi:10.1371/journal.ppat.1000035.g006
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panel). Most importantly, however, core and NS5A staining no
longer co-localized arguing that domain III in NS5A is required
for colocalization with core.
These results were fully confirmed by immuno electronmicro-
scopy (Figure 7B and the quantification summarized in Table 1).
Core and NS5A colocalized on the surface of the same LD in cells
transfected with the Jc1 wild type (upper panel). In contrast, in
case of the domain III deletion mutant, only very rarely core and
NS5A were found on the surface of the same LD even though the
antigen amounts were much higher as compared to the wild type
(Figure 7B, lower panel and Table 1). However, core – NS5A
colocalization was detected in case of the envelope gene deletion
mutant. In summary these data clearly show that domain III of
NS5A is required for colocalization with core on the surface of
LDs. In the light of an earlier report [10] the results thus imply
that domain III-dependent recruitment of NS5A (or the viral
Figure 7. Disruption of NS5A – core colocalization on LDs by deletion of NS5A domain III. (A) Cells transfected with the Jc1 wild type, the
envelope deletion mutant (Jc1/DE1E2) or the domain III deletion mutant (Jc1/D2328-2435) were grown on coverslips and double labeled with core-
and NS5A-specific antibodies; LDs were stained with BODIPY493/503 (green) and the nuclei with DAPI. Subcellular distribution of HCV proteins on
LDs was analyzed by confocal fluorescence microscopy. For enhanced clarity of 3-dimensional distribution of markers, the image stacks were
deconvolved as described in Materials and Methods. The deconvolved z-stacks are shown in a projection including a shadow cast to create a 3-
dimensional impression. Arrows refer to LDs with core – NS5A colocalization. Numbers and arrows in the upper and middle panel indicate
colocalization patterns as described in the text. (B) Detection of HCV core and NS5A in transfected cells by using immuno electron microscopy. Cells
transfected with the Jc1 wild type, the envelope deletion mutant and the NS5A mutant were grown in 10 cm
2 cell culture dishes and fixed after
48 hours. Thawed cryosections were prepared (as described in Materials and Methods) and double-labeled with antibodies to HCV NS5A (10-nm-
diameter protein A-gold) and HCV Core (15-nm-diameter protein A-gold). Bars, 200 nm. LD, lipid droplet. A quantification of the immunolabeling is
summarized in Table 1.
doi:10.1371/journal.ppat.1000035.g007
Table 1. Average amount of gold particles on the membrane
of LDs in cells that had been transfected with Jc1 wild type or
Jc1/DE1E2 or Jc1/D2328-2435 (exemplified by Figure 7B).
Jc1 Jc1/DE1/E2 Jc1/D2328-2435
Anti-core 1.21 3.48 3.16
Anti-NS5A 2.06 2.59 2.46
The data are based on two different labeling experiments, two grids per
experiment considering 20 lipid droplets per grid. Only the labeling on the
membrane around the LD was considered, and not labeling on adjacent
vesicles or the ER membrane. Statistically significant differences were only
observed in case of core labeling between Jc1 wild type and the two mutants
(p-value ,0.0001 as determined by t-test), but not between the two mutants.
Likewise, labeling density of NS5A did not differ between the three constructs
in a statistically significant manner.
doi:10.1371/journal.ppat.1000035.t001
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assembly.
Rescue of HCV particle assembly by trans-
complementation of NS5A deletion mutants
NS5A is a component of the viral replicase and therefore
involved in RNA replication. Recently we showed that replication-
incompetent NS5A mutants could be rescued by trans-comple-
mentation [30]. Having now found that NS5A is involved in HCV
assembly, we were interested whether this NS5A function can also
be restored by trans-complementation. To this end we established
a trans-complementation assay based on the co-transfection of a
Jc1 genome carrying the deletion in domain III of NS5A (D2328-
2435) with a subgenomic luciferase-helper RNA that lacks the
region encoding core to the C-terminus of NS2 (Figure 1A).
Replication of this helper RNA was determined by luciferase assay
(Figure 8B). In addition, for control purposes we included
cotransfections of Jc1 wild type with the helper RNA as well as
cotransfections of either of the Jc1 constructs with a defective
helper RNA that carried the large domain III deletion in NS5A
(Figure 8A). Depending on the particular combination of the
constructs, different outcomes were possible. Upon transfection of
cells with the wild type helper RNA and the Jc1 wild type genome,
we would expect the generation of infectious Jc1 particles
containing the full length wild type genome or, in case of trans-
packaging, the subgenomic helper RNA. In fact, upon inoculation
of naive Huh7.5 cells with supernatants from such transfected
cells, high level luciferase expression was detected indicating the
formation of virus-like particles which had encapsidated the
subgenomic helper RNA as a result of trans-packaging (Figure 8C).
Moreover, inoculated cells expressed high amounts of wild type
NS5A and core protein indicating efficient infection with Jc1 wild
type particles (Figure 8D). Upon cotransfection of cells with Jc1
wild type and the defective helper RNA (sg/lucD2328-2435),
infectious virus-like particles were generated that also transduced
the luciferase gene (Figure 8C). Formation of these particles was
most likely due to trans-complementation of the defective NS5A of
the helper RNA by wild type NS5A expressed from Jc1 and
subsequent trans-packaging of the helper RNA into virus-like
particles. In addition, infectious Jc1 particles were produced as
determined by high level core and NS5A expression in cells
inoculated with supernatant of the cotransfected cells (Figure 8D).
The epitope recognized by the NS5A-specific antibody used for
this immunofluorescence staining resides in domain III thus
allowing selective detection of wild type NS5A protein but not the
domain III deletion mutant.
In case of cells cotransfected with the Jc1-NS5A mutant (Jc1/
D2328-2435) and the wild type helper RNA (sg/lucwt) efficient
transduction of the luciferase gene was observed arguing for trans-
packaging of the helper RNA by the structural proteins provided
by the Jc1 mutant (Figure 8C). In addition, core expression in
infected cells was observed arguing for a rescue of the Jc1 mutant
by trans-complementation that was mediated by the intact NS5A
protein provided by the helper (Figure 8D). This assumption is
supported by the fact that most cells expressing well detectable
amounts of core protein did not express wild type NS5A protein
indicating that these cells indeed had been infected with the Jc1-
NS5A mutant. In contrast, cells expressing wild type NS5A
(expressed from the transduced helper RNA) did not express core
protein supporting the notion that these cells had been infected
with virus-like particles that had packaged the subgenomic helper
RNA.
Finally, in supernatants of cells cotransfected with the Jc1
mutant (Jc1/D2328-2435) and the defective helper RNA (sg/
lucD2328-2435) no infectivity was detected, neither by luciferase
assay (Figure 8C) nor by immunofluorescence (Figure 8D) and
TCID50 assay (not shown). This result supports the notion that the
Figure 8. Particle assembly of NS5A mutants can be rescued by
trans-complementation. (A) Schematic of the experimental ap-
proach. Genomic (Jc1) wild type or mutant RNA was cotransfected with
one of the given helper RNAs (sg/lucwt or sg/lucD2328-2435).
Replication of the helper was determined by luciferase assay. Release
of infectious particles from transfected cells was determined by
infection of naı ¨ve Huh7.5 cells with supernatants (sup.) from transfected
cells and subsequent analysis of infected cells (1
st passage) by luciferase
assay, immunofluorescence analysis or TCID50 assay. Infectivity release
from these infected cells was determined by subsequent inoculation of
naı ¨ve Huh7.5 cells (2
nd passage) with the corresponding supernatants
(sup.) and infection was determined by luciferase assay or TCID50 assay.
(B) Transient replication of sg/luc helper RNAs 24, 48 and 72 h after co-
transfection with Jc1 wild type or the Jc1/D2328-2435 mutant. (C)
Supernatants from transfected cells (panel B) were harvested 24, 48 and
72 h post transfection and used for inoculation of naı ¨ve Huh7.5 cells.
The level of trans-packaged or trans-complemented helper RNA was
determined by luciferase assay with cells 72 h after inoculation. (D)
Supernatants from transfected cells (panel B) were harvested 48 h post
transfection and used for inoculation of naı ¨ve Huh7.5 cells. Seventy two
hours after inoculation cells were fixed and NS5A or core protein were
detected by immunofluorescence. Nuclei of cells were stained with
DAPI. (E) Supernatants from cells after first passage were harvested 72 h
post infection and used to inoculate naı ¨ve Huh7.5 cells. Infectivity in the
supernatant of these cells was determined by TCID50 assay with
supernatant harvested 72 h post inoculation. Values shown in panels B,
C and E represent the mean of two independent experiments, each
measured in duplicate and the error bars.
doi:10.1371/journal.ppat.1000035.g008
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deletion in domain III indeed is unable to support virus assembly.
To exclude the possibility of RNA recombination between the
Jc1-NS5A mutant and the wild type helper RNA resulting in a
wild type Jc1 genome, supernatants from primary infected cells
were passaged (Figure 8A; 2
nd passage). Supernatants from such
inoculated cells were then analyzed for infectivity by using
luciferase assay (not shown) and TCID50 assay (Figure 8E).
However, in no case infectivity was detected excluding the
possibility that a Jc1 wild type with or without a luciferase gene
was generated by RNA recombination.
In conclusion these results demonstrate that also alterations
affecting the assembly/virus release function of NS5A can be
restored by trans-complementation. The data also show that
subgenomic HCV RNAs can be packaged efficiently into
infectious HCV-like particles.
Discussion
A hallmark of the HCV replication cycle is its extraordinary
dependance on host cell lipids. Several groups have shown that
viral RNA replication is tightly linked to lipid synthesis pathways
and sensitive to pharmacological intervention with statins and
certain fatty acids [31–33]. More recently it became apparent that
HCV particle morphogenesis and egress also depend on host cell
lipids [34]. Taking advantage of the newly established cell culture
system to produce infectious virus particles, evidence was obtained
that HCV assembly occurs in close association with LDs [10,12].
It was suggested that core protein accumulates on the surface of
LDs and recruits the RC, and thus the viral RNA, in order to
trigger particle formation [10]. However, the mechanisms of RC
recruitment and initiation of assembly are not known. In this
study, we show that NS5A, in addition to core, is a key element of
particle formation. The primary determinant within NS5A is
domain III. Interestingly, deletions affecting this domain do not
abrogate LD association of NS5A suggesting that LD association is
mediated by some other domain(s) within NS5A, the most likely
being domain I, eventually in conjunction with the N-terminal
amphipathic alpha-helix (10). However, domain III deletions
affect colocalization with core protein on the surface of the same
LD. This result implies that different types of LDs are formed in
case of the mutant: those that contain primarily core protein and
those that contain almost exclusively NS5A (Figure 7B). The
underlying mechanism is not known but it is possible that core
protein has a strong binding affinity to LDs and thus heavily
occupies the surface of LDs. This would leave only limited
access for NS5A to the surface of such a LD. In case of wild
type NS5A facilitated by an (direct or indirect) interaction
between NS5A and core, both proteins can accumulate on the
surface of the same LD. In case of the domain III deletion mutant,
the core – NS5A interaction would be disrupted and thus, this
mutant NS5A protein would primarily accumulate on LDs not
occupied by core protein. Further studies are necessary to address
this possibility.
The fact that deletions in domain III perturb colocalization with
core on LDs and at the same time impair infectious virus
production provides compelling evidence that both events are
linked. The data support a model in which core recruits either
NS5A or the NS5A-containing RC via direct interaction with
domain III to the assembly site. In agreement with this assumption
a direct core – NS5A interaction has been demonstrated in an
overexpression system by using coprecipitation and colocalization
studies [35,36]. We also attempted to demonstrate a direct core –
NS5A interaction by using infected or transfected cells as well as
over-expression systems. Neither by co-immunoprecipitation with
or without cross-linking nor by using fluorescence resonance
energy transfer assays we were able to demonstrate such an
interaction. Differences in the experimental set up as well as
differences in the used HCV isolates (genotype 2a (JFH-1) versus
genotype 1a and 1b in the previous studies) could account for this
discrepancy. However, it is well possible that in a more authentic
(virus production) system such a core – NS5A interaction is very
unstable and transient. It is also conceivable that within an
assembly competent replication system only a minor fraction of
total NS5A and core protein is enganged in an interaction.
Moreover, once RNA transfer from the RC (or NS5A) to core has
been initiated, a self-assembly process driven by core – RNA
interaction may take place that no longer depends on an
interaction between core and NS5A. It is even possible that core
and NS5A do not directly interact but that exposed RNA regions
not complexed by NS5A are recognized by core protein residing in
close proximity to NS5A and sufficient to trigger assembly. In this
respect colocalization of core and NS5A on the surface of the same
LD or in close proximity to each other may be sufficient to allow
particle formation. Finally, NS5A – core interaction may be
indirect and facilitated by host cell factors. Several NS5A binding
proteins have been described such as VAP-A/B and VPS35 that
are involved in intracellular trafficking or apolipoproteins involved
in the formation of lipoproteins [35,37]. The contribution of these
host cell factors for virion formation remains, however, to be
determined. It is also unclear why HCV utilizes this unique
pathway of virion formation and where exactly envelopement of
the nucleocapsid occurs. In agreement with earlier observations
[10], we found that E2 also accumulated in close proximity of LDs
(N.A., M.Z. T.S. and R.B., unpublished). It is therefore plausible
that LDs tightly surrounded by ER membranes are the sites where
nucleocapsids form, which could then acquire their envelope via
budding into the ER lumen at sites in close proximity of LDs.
Further studies are required to address this important question.
At least two important consequences arise from an assembly
model that is based on a RC (NS5A) – core interaction. First,
specificity of RNA encapsidation would primarily be brought
about by protein – protein rather than protein – RNA interaction.
While the genome of several viruses, such as e.g. the hepatitis B
virus, contain a distinct RNA element that is recognized by a viral
protein to mediate selective genome packaging [38], such a
packaging signal would not be required for HCV. Second,
mutations in NS5A affecting RNA binding or core interaction
would interfere with assembly and thus lead to an accumulation of
core on the surface of LDs.
It is interesting to note that NS5A, especially the so-called V3
region of domain III is amongst the most variable sequences across
the different genotypes and subtypes [39]. Therefore, it is well
possible that NS5A variants differ in their efficiency for infectious
particle assembly. Inefficient assembly results in an accumulation
of core protein on the surface of LDs [11] and intracellular
accumulation of core can lead to perturbation of host cell lipid
metabolism such as interference with microsomal triglyceride
transfer protein activity and very-low density lipoprotein (VLDL)
secretion [40]. Thus, both core and NS5A may contribute to
pathogenesis, especially HCV-induced steatosis.
In agreement with earlier studies, we found that deletions
affecting domain III have no or minimal impact on RNA
replication [29,41]. However, insertion of a heterologous sequence
into the coding region of domain III impairs virus production [42].
In the light of the present data the most likely explanation for this
phenotype is that the insertion interferes with the assembly
function of domain III. To our great surprise we also found that a
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on RNA replication and almost no effect on virion production
arguing that domain II serves some other purpose not directly
contributing to the replication cycle such as interaction with the
host cell. This result is to some extent at variance to a recent report
by Tellinghuisen and colleagues [41] showing that a 10 amino acid
deletion in domain II (deletion B) overlapping the larger deletion
that we describe here (D2222-2280) blocks RNA replication. This
discrepancy may be due to the different experimental systems used
in their and our study [genotype 1b (Con1) derived subgenomic
replicons versus JFH-1 derived genomes, respectively]. Moreover,
it is interesting to note that only for deletion B Tellinghuisen and
colleagues could not identify a single amino acid responsible for
the non-replicating phenotype arguing that the complete region
rather than a specific amino acid is required for RNA replication.
Since the overall amino acid sequence homology of NS5A
between Con1 and JFH-1 is about 61%, but only about 50% in
case of domain II, it is possible that in JFH-1 other regions of the
NS5A sequence are required for efficient RNA replication.
Nevertheless, when we deleted the complete domain II, replication
of JFH-1 was also completely blocked (not shown). This
observation fits to the results by Tellinghuisen and colleagues,
who showed that 10 amino acid deletions affecting the C-terminal
half of domain II prevent RNA replication completely [41].
By using a cotransfection approach of a NS5A mutant genome
with a subgenomic helper RNA we demonstrate that both trans-
complementation and trans-packaging occur. Trans-complemen-
tation means that the mutant RNA genome that due to a deletion
of domain III is not assembly competent can be rescued by
providing NS5A (expressed in the context of a replicase) in trans.
The result is a virus-like particle that contains the mutant genome
and thus upon infection of naı ¨ve cells can not spread in culture due
to the assembly defect. The molecular mechanisms underlying this
trans-complementation are not known and therefore we can only
speculate. In one possible scenario mixed replication complexes
form composed of the genomic NS5A mutant and the subgenomic
helper, allowing wild type NS5A to interact with mutant RNA and
thus ‘tagging’ the mutant RNA genome for encapsidation.
Whatever the underlying mechanism is, preliminary results suggest
that NS5A expressed on its own does not support trans-
complementation, but only when NS5A is expressed in the
context of the replicase (NS3 to NS5B; N.A., S.K. and R.B.
unpublished). Thus, the pre-conditions required to rescue
assembly-defective mutants by trans-complementation with
NS5A appear to be similar to those required to rescue NS5A
mutants that are defective in RNA replication (30).
Apart from trans-complementation we also observed trans-
packaging which refers to the encapsidation of the subgenomic
helper RNA into virus-like particles. These particles are infectious
but due to the subgenomic nature of the encapsidated RNA, no
infectious virus progeny is generated and thus there is no spread in
cell culture. Trans-packaging has also been described for
numerous other viruses including alphaviruses as well as several
members of the pesti- and flaviviruses [43,44]. In these cases trans-
packaging has been achieved by several different strategies
including packaging defective helper constructs or helper cell
lines that stably express the structural genes. Moreover, trans-
packaging of subgenomic RNAs has been observed in vivo and is
refered to as defective-interfering particles which means the
formation of virus-like particles that contain an RNA subgenome
and that upon co-infection of a cell with a wild type genome
interfere with wild type RNA replication [45]. A recent report
suggests that such particles are also formed in HCV-infected
patients [46].
In summary, we demonstrate that NS5A is a major determinant
for infectious virus production and show that domain III is most
critical for this step in the viral replication cycle. In the light of this
observation and given the essential role of NS5A for RNA
replication, this protein is a novel and promising target for
antiviral therapy. Several inhibitors targeting the replication
function of NS5A have been described and it will be interesting
to determine whether they also impact virus particle production
and thus follow a two-pronged mode-of-action.
Materials and Methods
Plasmids
Plasmids pFK-Jc1 and pFK-Luc-JFH1 have been described
previously (Wakita 2005; Pietschmann 2006). PFK-Jc1/DE1E2 that
carries a deletion of 350 codons in the E1-E2 coding region
(removing amino acids218–567 of the J6polyprotein) andthe NS5A
deletions were generated by PCR-based mutagenesis. All PCR-
amplified DNA fragments were analyzed by automated nucleotide
sequencing using an ABI 310 sequencer (Applied Biosystems). Big
Dye version 1.1 (Applied Biosystems) was used for cycle sequencing
according to the manufacturer’s protocol. Detailed information
about DNA cloning is available in Protocol S1.
Cell culture and infectivity assays
Huh-7 cell clones Huh7-Lunet [47] and Huh7.5 [48] that both
are highly permissive for HCV RNA replication were used for
electroporation and infection assays, respectively. Luciferase
reporter virus-associated infectivity was determined as described
elsewhere [49]. Infectivity of HCV variants lacking a reporter gene
was determined by using a limiting dilution assay on Huh-7.5 cells
[50] with a few minor modifications. Infected cells were detected
by using a JFH1 NS3-specific rabbit polyclonal antiserum as
primary antibody (dilution 1:500) and a peroxidase-conjugated
goat anti-rabbit polyclonal antibody (Sigma) as a secundary
antibody (dilution 1:1,000). The tissue culture 50% infectivity dose
(TCID50) was calculated as described recently [51]. Intracellular
infectivity assays as determined with freeze – thaw lysates of
transfected cells were performed according to a published protocol
[52]. In brief, 48 h post-transfection Huh7-Lunet cells were
extensively washed with PBS, scraped off the plate and centrifuged
for 5 min at 7006g. Cell pellets were resuspended in 1 ml of
DMEM containing 5% FCS and subjected to three cycles of
freezing and thawing using liquid nitrogen and a thermo block set
to 37uC. Samples were then centrifuged at 10,0006g for 10 min at
4uC to remove cell debris, and cell-associated infectivity was
determined by TCID50 assay. Culture supernatants from trans-
fected cells were treated in the same way and infectivity was
determined in parallel.
Transient HCV replication and trans-complementation
assay
Transient HCV RNA replication assays were performed as
described previously [53]. In brief, plasmid DNA was restricted
with MluI and used for in vitro transcription. Ten mg of run-off
transcripts were used for electroporation of 4610
6 Huh7-Lunet
cells that were resuspended in 20 ml culture medium (12 ml in
case of freeze and thaw experiments). Two ml aliquots were seeded
per well of a 6-well plate and replication was determined by
measuring luciferase activity in case of genomes containing the
luciferase reporter gene at 4, 24, 48 and 72 h post-electroporation.
Since luciferase activity measurable 4 h post transfection is derived
from transfected input RNA, these values were used to normalize
for transfection efficiency. In case of authentic virus genomes
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by Northern blot analysis as described in Protocol S1. For trans-
complementation assays, Huh7-Lunet cells were co-transfected
with 5 mg of Jc1 genomes and 0.5 mg of helper RNAs containing a
luciferase reporter gene (corresponding to a 1:0.1 molar ratio,
respectively). Electroporated cells were seeded as described above
and replication of the non-reporter genome was determined by
Northern-blot analysis. Transient replication of helper RNAs was
determined by luciferase assay 4, 24, 48 and 72 h after
electroporation. Values obtained 4 h post electroporation were
used to determine the transfection effciency. Supernatants were
harvested 24, 48 and 72 h after eletroporation and concentrated
three times by using Amicon columns (Millipore, Schwalbach)
according to the instructions of the manufacturer. Release of
infectious particles from co-transfected cells was determined by
TCID50 assay by using the concentrated culture supernatants.
Replication of trans-packaged subgenomic helper RNA was
determined by luciferase assay performed with lysates of Huh
7.5 cells that had been inoculated with the concentrated culture
supernatants of co-transfected cells.
Quantification of HCV core protein by Elisa
Core protein amounts were determined by using the Trak-C
Core ELISA (Ortho Clinical Diagnostics) as recently described
[51]. Since core protein amounts measurable 4 h after transfection
are derived from transfected input RNA, these values were used to
normalize for transfection efficiency.
Protein precipitation, phosphatase treatment and
Western blot analysis
Huh7-Lunet cells electroporated with Jc1 genomes were seeded
into a 10 cm diameter culture dish. Seventy two hours post
electroporation cells were washed two times with ice-cold
phosphate-buffer saline (PBS) and harvested by scraping into
500 ml RIPA buffer (50 mM Tris-HCl [pH 7.4], 1% Nonidet P-
40, 0.25% sodium desoxycholate, 150 mM NaCl, supplemented
with protease inhibitors (1 mM PMSF; 0.001 U/ml aprotinin and
4 mg/ml leupeptin). The cell lysate was divided into two aliquots,
mixed with 4 volumes of acidified acetone/methanol and
incubated at 220uC over night. Proteins were pelleted by
centrifugation at 15,0006g for 15 min, pellets were air dried
and resuspended in 200 ml of lambda phosphatase buffer (50 mM
Tris HCl [pH 7.5], 100 mM NaCl, 0.1 mM EGTA, 2 mM DTT,
0.01% Brij35) supplemented with 2 mM MnCl2 and 0.4% NP-40.
One hundred ml of the sample was incubated with 4,000 units of
lambda protein phosphatase (Biolabs) at room temperature (RT)
for 45 min. Samples were then mixed with SDS-PAGE loading
buffer [200 mM Tris-HCl [pH8.8], 5 mM EDTA, 0.1% bromo-
phenol blue (w/v), 10% sucrose (w/v), 3% SDS (w/v) and 2%
beta-mercaptoethanol (v/v)], separated by electrophoresis into an
8% polyacrylamide gel and transferred to a PVDF membrane.
NS5A was detected by immunobloting using a JFH-1 NS5A-
specific rabbit polyclonal antiserum (dilution 1:1,000) and
peroxidase-conjugated goat anti-rabbit polyclonal antibody (dilu-
tion 1:25,000). Bound secondary antibody was detected by using
the ECL Plus Western Blotting Detection system (Amersham)
according to the instructions of the manufacturer.
Immunofluorescence analyses and image deconvolution
Transfected Huh7-Lunet cells were seeded into 24 well-plates
containing glass coverslips. Seventy two hours after electropora-
tion, cells were washed twice with PBS, fixed with 4%
paraformaldehyde in 150 mM sodium cacodylate buffer
[pH 7.5] for 15 min at RT and permeabalized with digitonine
(50 mg/ml) for 5 min at RT. Permeabilzed cells were washed twice
with PBS and blocked with PBS containing 5% (w/v) bovine
serum albumine (Sigma) for 30 min at RT. NS5A was detected by
using a NS5A-specific monoclonal antibody (Austral Biologicals,
San Ramon, CA) at a dilution of 1:200; core and NS4B were
detected with monospecific rabbit polyclonal antisera C-830
(dilution 1:200) or serum #86 (dilution 1:100), respectively. After
1 h at RT, cells were washed three times with PBS and incubated
with a 1:1,000 dilution of Alexa 488, 546 or 647-conjugated
secondary antibody (Invitrogen, Molecular Probes) in PBS - 5%
BSA for 1 h in the dark. LDs were stained with 20 mg/ml of
BODIPY493/503 (Invitrogen, Molecular Probes) during second-
ary antibody incubation. Cells were washed once with PBS,
incubated for 1 min with a 1:5,000 diluted solution of 49,6 9-
diamidino-2-phenylindole dihydrochloride (DAPI)-PBS, and im-
mediately washed four times for 10 min with PBS. Cells were
mounted on glass slides with Slow-Fade Gold Antifade Reagent
(Invitrogen, Molecular Probes). For double staining images were
acquired on a Nikon C1Si spectral imaging confocal laser
scanning system on a TE-2000 E equipped with 606 Objective
(NA 1.4). For 3-D reconstruction of samples stained with 3 or 4
markers, cells were imaged on an Ultraview ERS spinning disk
(PerkinElmer Life Sciences) on a Nikon TE2000-E inverted
confocal microscope equipped with a Plan-Apochromat VC 100X
lens (NA 1.4). Channels were recorded sequentially onto an EM-
CCD camera by using an emission discrimination option in the
following order: 647/700, 568/610, 488/510, 405/440 (emission/
excitation). For deconvolution, optical slices were acquired at 0.15-
mm Z spacing resulting in a stack of 30–40 optical slices per cell.
Colocalization of fluorescence signals was evaluated quantitatively
for Pearson’s correlation coefficient (Rr) by using the plugin
‘Intensity Correlation Analysis’ of the ‘Image J’ software. For each
sample 50 cells were analyzed. Core-LD colocalization was
calculated by counting the total number of LDs in a cell and the
number of those LDs with an overlapping core protein signal. The
plugin ‘RG2B’ colocalization software of Image J was used to
detect overlapping signals. Deconvolution of image z-stacks was
performed based on a theoretical point spread function by using
Huygens Essential software (v. 3.0, Scientific Volume Imaging
BV). The 3D projections of deconvolved images were reconstruct-
ed with the help of the simulated fluorescence process volume
rendering algorithm of the Huygens Essential software. In case of
trans-complementation assays (Figure 8D), infected Huh 7.5 cells
were treated as described above, but NS5A was detected with
monoclonal antibody 9E10 [50] and images were acquired with an
inverted fluorescence microscope (Leica, Germany).
Immunoelectron microscopy
For immuno-EM Huh7.5 cells grown in 10 cm
2 dishes were
transfected with viral RNA as described above. Forty eight hours
post transfection the cells were fixed in 4% paraformaldehyde,
0.1% glutaraldehyde, and 1% acrolein in PHEM buffer (240 mM
Pipes, 100 mM Hepes, 8 mM MgCl2, 40 mM EGTA; pH 6.9).
Cells were scraped off the dish, pelleted, and incubated in 2.3 M
sucrose overnight at 4uC. Subsequently, cell pellets were mounted
on silver pins, flash frozen and stored in liquid nitrogen. The
specimens were sectioned with a Reichert Ultracut S ultramicro-
tome with a Reichert FCS cryo-attachment using a Diatome
diamond knife (Diatome, Biel, Switzerland). Double-labeling of
thawed cryo-sections was performed as described [54,55]. Protein
A-gold (Utrecht University, Utrecht, Netherlands) of different sizes
was used to label different viral proteins. EM specimens were
examined using a Zeiss EM10 transmission electron microscope.
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done using three different labeling experiments considering two
grids per experiments. The average labeling per lipid droplet was
estimated by considering 20 profiles of lipid droplets per grids and
by counting the labeling on the surrounding membrane of the LD
only. Statistical analysis was done by t-test using the free p- value
calculater for 158 degree of freedom (http://www.graphpad.com/
quickcalcs/Pvalue2.cfm).
Supporting Information
Protocol S1 Plasmid Construction and Northern Blot
Found at: doi:10.1371/journal.ppat.1000035.s001 (0.03 MB
DOC)
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